Prostaglandin synthesis inhibition reduces platelet aggregation in diabetes mellitus.
Platelet aggregation, platelet prostaglandin precursor fatty acids, glycaemia and lipid levels were studied in a group of insulin dependent diabetics whilst taking Aspirin (900 mg daily) and Dipyridamole (300 mg daily) and again two months after discontinuing this treatment.
D001241:Aspirin / Q000494:pharmacology; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D004176:Dipyridamole / Q000494:pharmacology; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000096:biosynthesis*
D011453:Prostaglandins; D004176:Dipyridamole; D001241:Aspirin